Assignee
HEPION PHARMACEUTICALS INC
US·1 granted patent·8 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
9 records- 0169US2023390199A1Generating a microemulsion formation with improved solubilityHEPION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0269US2023390198A1Forming a self-microemulsifying drug delivery systemHEPION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0364US2025057807A1Treating a disease using a pharmaceutically active ingredient present in a pseudo-ternary phase systemHEPION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0464US2023398174A1Pseudo-ternary phase system for improving solubility of a pharmaceutically active ingredientHEPION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0561US2020163876A1Pharmaceutical formulations of cyclosporine analogsHEPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0660US2025360181A1Use of cyclosporine analogues for treating fibrosisHEPION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0755US12409206B2Use of cyclosporine analogues for treating fibrosisHEPION PHARMACEUTICALS INC·Filed 2021·Granted Sep 9, 2025·0 cites·19 claims
- 0845US2022168385A1Use of cyclosporine analogues as antithrombotic agentsHEPION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0940US2021269479A1Use of cyclosporine analogues for treating cancerHEPION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →